Stay Informed
Sign up to automatically receive Neurocrine Biosciences financial information by email
Webcasts & Presentations
Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.
March 11, 2025
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
SAN DIEGO, March 11, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025. Chief Executive Officer Kyle Gano and Vice-President of Business Development and Strategy Samir Siddhanti will present at the conference.
February 25, 2025
Neurocrine Biosciences to Present at the Leerink Global Healthcare Conference
SAN DIEGO, February 25, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Leerink Global Healthcare Conference on Tuesday, March 11, 2025 at 11:20 a.m. Eastern Time in Miami. Chief Financial Officer Matt Abernethy and Vice-President of Investor Relations Todd Tushla will present at the conference.
February 25, 2025
Neurocrine Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
SAN DIEGO, February 25, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the TD Cowen 45th Annual Health Care Conference at 11:10 a.m. Eastern Time on Tuesday, March 4, 2025 in Boston. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Chief Commercial Officer Eric Benevich will present at the conference.
Resources